Linda, I wish I knew what it will be too. My gut is telling me there will be some HEB NEWS coming soon, not only related to earnings, but also AMP-516
trials and possible new financing or
partnering with a major like PNU. As we know this is a speculative stock, but I'm very encouraged that HEB is sitting
on the verge of a new 52 week and all-time historical high, when many stocks have been correcting or developing downtrends. This Relative Strength factor is very important to traders. Many professional traders will not participate in stocks under $5.00, and since HEB is testing that resistance level, the possibility of increasing the number of market participants for HEB's stock substantially is very real. The money has to go somewhere, and the timing could be in HEB's favor right now. I'm very impressed with HEB's capital structure at the present time too. When the new AMEX listing occured, there was alot of testing of support at the $3 3/4- 4.00 level; ie, "out of and
at the money level" for the warrants.
Now, the situation has changed, and the warrants are "in the money" with the new millenium for an investor's time target.
I think investors are looking for new and interesting ideas for that kind of time horizon. The 2000 "bug" story is long in the tooth and there are dozens, if not more companies, competing for solutions. HEB is in a much more unique situation, and hopefully the efficacy of HEB's hundreds of RNA patents will develop from speculative to quality issue.
mg |
